CohBar discoveries "a shocker to scientists" says CEO

Californian aging specialist CohBar (Nasdaq: CWBR) is using mitochondrial science to treat diseases, but chief executive Steven Engle doesn’t rule out offering a “cure for aging” at some point.

Asked whether the firm could find itself developing products for healthy people to take, with the specific purpose of extending healthy lifespan, he says: “Yes, I think that's possible.”

He points to the example of metformin, a commonly used compound for diabetics, which he says “actually has positive effects on things like cancer.”